Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07LYW
|
|||
Former ID |
DNC006492
|
|||
Drug Name |
2-valproylamido-5-sulfonamidoindane
|
|||
Synonyms |
CHEMBL381730; 2-valproylamido-5-sulfonamidoindane; Indanesulfonamide Derivative 12a; BDBM11031
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H26N2O3S
|
|||
Canonical SMILES |
CCCC(CCC)C(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)N
|
|||
InChI |
1S/C17H26N2O3S/c1-3-5-12(6-4-2)17(20)19-15-9-13-7-8-16(23(18,21)22)11-14(13)10-15/h7-8,11-12,15H,3-6,9-10H2,1-2H3,(H,19,20)(H2,18,21,22)
|
|||
InChIKey |
XBYJCVDSFWJBSM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J Med Chem. 2006 May 4;49(9):2743-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.